Cargando…
Monitoring the Crosstalk Between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 with PET
PURPOSE: Ovarian cancer (OC) leads to poor survival rates mainly due to late stage detection and innate or acquired resistance to chemotherapy. Thus, efforts have been made to exploit the estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) to treat OC. However, patients eventu...
Autores principales: | Antunes, I. F., Hospers, G. A. P., Sijbesma, J. W. A., Boerema, A. S., van Waarde, A., Glaudemans, A. W. J. M, Dierckx, R. A. J. O., de Vries, E. G. E., de Vries, E. F. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497457/ https://www.ncbi.nlm.nih.gov/pubmed/32285356 http://dx.doi.org/10.1007/s11307-020-01496-7 |
Ejemplares similares
-
Analyzing the Estrogen Receptor Status of Liver Metastases with [(18)F]-FES-PET in Patients with Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2021) -
N-[(11)C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic Drugs
por: Hartimath, S. V., et al.
Publicado: (2016) -
Pharmacokinetic Modeling of [(11)C]GSK-189254,
PET Tracer Targeting H(3) Receptors, in Rat Brain
por: Ghazanfari, Nafiseh, et al.
Publicado: (2022) -
Allosteric Interactions between Adenosine A(2A) and Dopamine D(2) Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging
por: Prasad, Kavya, et al.
Publicado: (2021) -
Impact
of an Adenosine A(2A) Receptor Agonist
and Antagonist on Binding of the Dopamine D(2) Receptor Ligand
[(11)C]raclopride in the Rodent Striatum
por: Prasad, Kavya, et al.
Publicado: (2022)